The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Texas -- Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, toda [...]

Carlsbad, CA, 07/11/18– Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a definitive agreement to acquire LyoGe [...]

First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business Salt Lake City, UT, USA and South San Francisco, CA, USA, April 26th  2018.  Carter [...]

Seattle, WA, April 16, 2018 – RareCyte, Inc., a global rare cell detection and liquid biopsy company announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 1 [...]

SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expan [...]

Salt Lake City, Utah, USA… Carterra Inc., an innovative label-free biosensor company, announced today that it has sold multiple units of its new, fully integrated, high throughput monoclonal antibody (mAb) screening and characterization instrument, t [...]

Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization   Salt Lake City, Utah, USA…Carterra Inc., an innovative label-free biosensor company, has announced the cl [...]

AUSTIN, Texas-- Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests to hospital and reference labs, today announced that it has expanded its [...]

October 24, 2017 Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of a Series A funding round of $9.8 million led by Telegraph Hill Partners. This investment will enable Aquaro Histology [...]

San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based platform and new, highly sensitive iPLEX® HS chemistry for detection of somatic mutatio [...]